New Vaccine to Ward Off Tuberculosis Developed

by Sheela Philomena on  October 3, 2013 at 1:38 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new tuberculosis vaccine has been developed by researchers. The new vaccine was developed to act as a booster to Bacille Calmette Guerin (BCG), currently the only TB vaccine available.
 New Vaccine to Ward Off Tuberculosis Developed
New Vaccine to Ward Off Tuberculosis Developed

The vaccine, based on a genetically modified cold virus, was developed in the lab of Zhou Xing, professor of pathology and molecular medicine and the McMaster Immunology Research Centre, who co-led the phase one study with Dr. Fiona Smaill, professor and chair of the Department of Pathology and Molecular Medicine of the Michael G. DeGroote School of Medicine at McMaster.

BCG was developed in the 1920s and has been used worldwide. The new "booster" would reactivate immune elements that over time diminish following BCG vaccination.

The findings have been published in the journal Science Translational Medicine.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Tuberculosis Tracheostomy Pleural Effusion Silicosis Screening Tests for Tuberculosis Vaccination for Children Fever Cough Symptom Evaluation Diet in Tuberculosis Stomach Tuberculosis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...